DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+3.61%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$8.02B
AUM Growth
+$84.9M
(+1.1%)
Cap. Flow
-$6.67M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
22.36%
Holding
1,205
New
120
Increased
406
Reduced
545
Closed
56
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$14.8M |
| 2 |
CME Group
CME
|
+$11.9M |
| 3 |
Medtronic
MDT
|
+$11.7M |
| 4 |
Las Vegas Sands
LVS
|
+$11M |
| 5 |
AbbVie
ABBV
|
+$11M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$22.3M |
| 2 |
HP
HPQ
|
+$20.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$16.4M |
| 4 |
CGI
GIB
|
+$15.9M |
| 5 |
Scotiabank
BNS
|
+$10.8M |
Sector Composition
| 1 | Financials | 21.41% |
| 2 | Healthcare | 18.92% |
| 3 | Technology | 13.09% |
| 4 | Communication Services | 10.01% |
| 5 | Consumer Staples | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
AGCO
AGCO
$8.01B
| $1.69M | 0.02% |
35,418
-65,544
| -65% | -$3.13M |
|
477
Hologic
HOLX
$14.6B
| $1.69M | 0.02% |
50,978
+8,972
| +21% | +$297K |
|
|
GEVA
478
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.69M | 0.02% |
17,310
-490
| -3% | -$47.8K |
|
479
Brown-Forman Class B
BF.B
$12.9B
| $1.69M | 0.02% |
58,203
-1,075
| -2% | -$31.1K |
|
|
XL
480
DELISTED
XL Group Ltd.
XL
| $1.68M | 0.02% |
45,349
-498
| -1% | -$18.4K |
|
481
BorgWarner
BWA
$9.36B
| $1.68M | 0.02% |
31,360
-387
| -1% | -$20.7K |
|
482
Canadian Solar
CSIQ
$733M
| $1.67M | 0.02% |
+50,000
| New | +$1.67M |
|
483
TechnipFMC
FTI
$16.8B
| $1.66M | 0.02% |
60,147
+19,996
| +50% | +$551K |
|
484
Sherwin-Williams
SHW
$88.9B
| $1.66M | 0.02% |
17,610
+5,442
| +45% | +$511K |
|
|
XEC
485
DELISTED
CIMAREX ENERGY CO
XEC
| $1.63M | 0.02% |
14,266
+3,730
| +35% | +$425K |
|
486
Exelon
EXC
$43.8B
| $1.61M | 0.02% |
67,693
-14,314
| -17% | -$340K |
|
|
ANDV
487
DELISTED
Andeavor
ANDV
| $1.6M | 0.02% |
17,524
+5,874
| +50% | +$535K |
|
488
Neurocrine Biosciences
NBIX
$14B
| $1.58M | 0.02% |
39,900
-800
| -2% | -$31.8K |
|
489
UGI
UGI
$7.38B
| $1.58M | 0.02% |
48,416
+18,350
| +61% | +$598K |
|
490
Leggett & Platt
LEG
$1.33B
| $1.57M | 0.02% |
34,273
+31,034
| +958% | +$1.42M |
|
|
IPXL
491
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.57M | 0.02% |
33,400
-4,500
| -12% | -$211K |
|
492
Moody's
MCO
$90.7B
| $1.55M | 0.02% |
14,969
+6,598
| +79% | +$684K |
|
493
Bunge Global
BG
$16.4B
| $1.54M | 0.02% |
18,849
-14,834
| -44% | -$1.21M |
|
494
Mattel
MAT
$5.75B
| $1.53M | 0.02% |
67,513
-43,698
| -39% | -$993K |
|
495
Acadia Pharmaceuticals
ACAD
$4B
| $1.53M | 0.02% |
47,000
-6,300
| -12% | -$205K |
|
496
Liberty Media Series A
FWONA
$22.4B
| $1.53M | 0.02% |
58,450
+17,253
| +42% | +$452K |
|
|
HZNP
497
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.52M | 0.02% |
58,700
-5,000
| -8% | -$130K |
|
498
CF Industries
CF
$14.1B
| $1.52M | 0.02% |
26,240
-990
| -4% | -$57.3K |
|
499
IAC Inc
IAC
$2.88B
| $1.51M | 0.02% |
+125,337
| New | +$1.51M |
|
500
Dollar General
DG
$23.3B
| $1.51M | 0.02% |
20,019
-600
| -3% | -$45.2K |
|